Trial intelligence / Profile preview

IMRT Combined With Chemotherapy Versus IMRT Alone for Stage II Nasopharyngeal Carcinoma

NCT01187238Phase 2Completed

Sponsor
Chinese Academy of Medical Sciences
Start
May 2010
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Chinese Academy of Medical Sciences. Started May 2010; status: completed.

02

Drugs

cisplatin
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT01187238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01187238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call